pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 402 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 1
    LR-19155
    Head And Neck Squamous Cell Carcinoma (HNSC) LG Chem Ltd
  • Phase 1
    LS-01
    Esophageal Squamous Cell Carcinoma (ESCC) Guangzhou Liushun Biotechnology Co Ltd
  • Phase 1
    LSLBP-002
    Renal Cell Carcinoma Shanghai Lishan Biopharmaceuticals Co Ltd
  • Phase 1
← prev
page 8 of 14
next →
131
Pain89
Neurology1
LTZ-301
Diffuse Large B-Cell Lymphoma
LTZ Therapeutics Inc
  • Phase 1
    LYL-273
    Metastatic Colorectal Cancer$LYEL Lyell Immunopharma, Inc.
  • Phase 1
    LZ-001
    Non-Small Cell Lung Cancer Livzon Pharmaceutical Group Inc
  • Phase 1
    MB-101
    Brain Tumor$MBIO MUSTANG BIO, INC.
  • Phase 1
    MB-108
    Anaplastic Astrocytoma$MBIO MUSTANG BIO, INC.
  • Phase 1
    MBQ-167
    Triple-Negative Breast Cancer (TNBC) MBQ Pharma Inc
  • Phase 1
    MCLA-145
    Solid Tumor Merus NV
  • Phase 1
    MCM-998
    Multiple Myeloma (Kahler Disease)$NVS NOVARTIS AG
  • Phase 1
    MEM-288
    Cutaneous Squamous Cell Carcinoma (cSCC) Memgen Inc
  • Phase 1
    MEN-2312
    Hematological Tumor Stemline Therapeutics Inc
  • Phase 1
    MEN-2501
    Fallopian Tube Cancer Stemline Therapeutics Inc
  • Phase 1
    MGC-028
    Bile Duct Cancer (Cholangiocarcinoma)$MGNX MACROGENICS INC
  • Phase 1
    MGD-024
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…$MGNX MACROGENICS INC
  • Phase 1
    MO-03
    Metastatic Renal Cell Carcinoma Osel Inc
  • Phase 1
    MOMA-313
    Metastatic Breast Cancer Moma Therapeutics Inc
  • Phase 1
    MRX-2843
    Non-Small Cell Lung Cancer Meryx Inc
  • Phase 1
    MTI-201
    Metastatic Uveal Melanoma Modulation Therapeutics Inc
  • Phase 1
    NKT-3964
    Adenocarcinoma Of The Gastroesophageal Junction NiKang Therapeutics Inc
  • Phase 1
    NM-6603
    Colorectal Cancer Nucmito
  • Phase 1
    NMS-812
    Refractory Acute Myeloid Leukemia Nerviano Medical Sciences SRL
  • Phase 1
    NN-3201
    Adenoid Cystic Carcinoma (ACC) Novelty Nobility Inc
  • Phase 1
    NPX-887
    Adenocarcinoma Of The Gastroesophageal Junction NextPoint Therapeutics Inc
  • Phase 1
    NX-1607
    Adenocarcinoma Of The Gastroesophageal Junction$NRIX Nurix Therapeutics, Inc.
  • Phase 1
    NXP-900
    Cervical Cancer$NVCT Nuvectis Pharma, Inc.
  • Phase 1
    OP-3136
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$OLMA Olema Pharmaceuticals, Inc.
  • Phase 1
    OPN-6602
    Refractory Multiple Myeloma Opna Bio SA
  • Phase 1
    OTS-167
    Metastatic Breast Cancer OncoTherapy Science Inc